Legg Mason Asset Management’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-21,200
Closed -$1.15M 121
2015
Q3
$1.15M Sell
21,200
-1,000
-5% -$65.1K 1.17% 14
2015
Q2
$1.49M Sell
22,200
-1,900
-8% -$124K 1.35% 9
2015
Q1
$1.41M Sell
24,100
-3,400
-12% -$205K 1.15% 13
2014
Q4
$1.8M Sell
27,500
-3,500
-11% -$221K 1.36% 13
2014
Q3
$1.79M Sell
31,000
-3,700
-11% -$205K 1.26% 18
2014
Q2
$1.96M Sell
34,700
-3,100
-8% -$163K 1.24% 18
2014
Q1
$1.94M Sell
37,800
-4,300
-10% -$217K 1.14% 20
2013
Q4
$2.22M Sell
42,100
-7,700
-15% -$378K 1.28% 16
2013
Q3
$2.23M Sell
49,800
-4,400
-8% -$195K 1.21% 23
2013
Q2
$2.24M Buy
+54,200
New +$2.37M 1.2% 24

Other funds holding ABBV

Legg Mason Asset Management's ABBV Position: Q4 2015 in Review

Legg Mason Asset Management sold out of AbbVie (ABBV) in Q4 2015, closing a stake of 21,200 shares — an estimated $1.15M sold.

Legg Mason Asset Management first reported a position in ABBV in Q2 2013 and held it in 10 quarters. The position peaked at $2.24M in Q2 2013. 1,637 funds tracked by Wall St. Rank hold ABBV as of Q4 2015.

  • Legg Mason Asset Management reported no remaining AbbVie position as of Q4 2015 after selling out during the quarter.
  • Legg Mason Asset Management sold 21,200 AbbVie shares in Q4 2015, an estimated $1.15M.
  • Legg Mason Asset Management first reported a position in AbbVie in Q2 2013 and held it in 10 quarters.
  • Legg Mason Asset Management's AbbVie position peaked at $2.24M in Q2 2013.
  • 1,637 funds tracked by Wall St. Rank held AbbVie as of Q4 2015.

Based on Legg Mason Asset Management's 13F filing for Q4 2015, filed 16 Feb 2016.